As stated in a recently published information by Credence Research, Inc. “Global Novel Drug Delivery Systems (NDDS) industry – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022,” the Novel Drug Delivery Systems (NDDS) industry was valued at USD 165.4 Bn and is expected to reach USD 202.5 Bn by 2022, expanding at a CAGR of 2.7% from 2016 to 2022.
The novel drug delivery system (NDDS) provides a therapeutic amount of drug to the specific site in the body to accomplish promptly and then maintain the desired drug concentration. The drug- delivery system should deliver drug at a rate control by the necessarily of the body over a specified term of treatment. industry experts suggest that, There is a continuous growth in the industry of drug delivery systems and will continue to grow at an impressive rate in future also. The novel drug delivery technologies enable to formulate the novel drug delivery devices by incorporating the drug molecules into new delivery systems, thus providing numerous therapeutic and commercial advantages.
Browse the full report Novel Drug Delivery Systems (NDDS) Market http://www.credenceresearch.com/report/novel-drug-delivery-systems-ndds-market
It was observed that NDDS industry was segmented on the basis of route of administration, type of carrier and geographical region. In route of administration segment, injectable drug delivery system was observed as the largest industry in 2015 followed by oral drug delivery system. Injectable drug delivery system comprises of several benefits over other dosage forms in cases such as unconsciousness, nausea, in emergency clinical episodes. The injectable administration route is the most common and efficient for delivery of active drug substances with poor bio-availability and the drugs with a narrow therapeutic index. On the basis of type of carrier, liposomes and microspheres collectively attribute the largest share in the industry in terms of revenue (USD). The key factors assisting the growth of liposomes industry are such as, biologically active materials encapsulated within liposomes are protected to varying extent from immediate dilution or degradation which assists drug carrier systems for the transport of drugs and other bioactive capsules to disease-affected organs
Free Sample, Link : http://www.credenceresearch.com/sample-request/57875
Industry Competition Assessment:
The key players involved in the novel drug delivery systems (NDDS) industry are 3M Company, Abbott Laboratories Ltd., Amgen Inc., AstraZeneca Plc, Bausch & Lomb, Baxter International Inc., Bayer AG, Boehringer Ingelheim, Boston Scientific, Bristolmyers Squibb, Celgene Corporation, Cephalon, Inc., Genentech Inc., Genzyme Corporation, Glaxosmithkline Plc, Johnson & Johnson, Merck & Co., Novartis AG, Pfizer Inc., Roche Holding AG, Sanofi SA, and Teva Pharmaceutical Industries Ltd.
Key industry Movements:
North America is expected to lead the global novel drug delivery systems industry due to high disposable income, increasing research and development activities associated with development of drug delivery systems, high adoption rate of novel technologies and supportive reimbursement policies.
Projected industry entry of several products and technologies during 2016 to 2022 in global novel drug delivery systems industry are expected to provide an exceptional growth to the industry
Novel drug delivery systems industry is expected to intensify the industry competition, ignition of price wars, and drive emphasis towards geographical expansion and penetration strategies to sustain in the competition
Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US